Healthcare ❯ Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs Oncology Market Trends Clinical Research GLP-1 Drugs Regulatory Approval Generic Drugs Obesity Treatment Market Competition

Odyssey Therapeutics Shares Rise 11% in Nasdaq Debut After $279 Million IPO

The strong opening signals fresh investor appetite for new biotech listings.

Analysts Lift Eli Lilly Targets After Blowout Quarter and Foundayo Debut

Eli Lilly Pours $4.5 Billion Into Indiana Plants, Opens Genetic-Medicine Site

Pfizer Beats Q1 Forecasts as Newer Drugs Offset COVID Slide

Axsome Reports 57% Q1 Sales Jump as FDA Clears Auvelity for Alzheimer’s Agitation

Pfizer Tops Q1 Forecasts on Eliquis Strength, Reaffirms 2026 Outlook

Doctors Outline Safe Use of Peptides as FDA Weighs Easing Restrictions

Pfizer Settles With Three Generics to Keep Vyndamax Exclusive Until 2031

Merck Reports Q1 Loss From Cidara Charge as Sales Beat and 2026 Outlook Rises

Regeneron Tops Q1 Estimates as Dupixent and Libtayo Outpace Eylea

AstraZeneca Tops Q1 Forecasts, Reaffirms 2026 Outlook as Oncology Fuels Growth

AbbVie Tops Q1 and Raises 2026 Outlook as Skyrizi and Rinvoq Offset Humira Decline

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Pfizer Sets 2026 Targets and Marks 350th Straight Dividend

Sagimet Prices $175 Million Stock Offering as It Plans U.S. Phase 3 Acne Trial

WHO Prequalifies First Malaria Treatment for Newborns

Hims & Hers Expands Access to Lilly Weight-Loss Drugs as Shares Jump 7%

Boehringer Ingelheim to Invest £150 Million in London AI Drug Discovery Centre

Johnson & Johnson Tops Q1 Forecasts and Lifts 2026 Outlook

AWS Launches Amazon Bio Discovery to Speed Early Drug Discovery